Monday, July 20, 2009

Benlysta Effective in Some Lupus Sufferers

GlaxoSmithKline and Human Genome Sciences limited the drug's Phase 3 trial to patients testing positive for the protein that Benlysta blocks, greatly boosting trial results, more 
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)